Gene Green: “Would you work with us on legislation to ensure that we do not impede or inhibit or otherwise disincentivize research?”

While were a still great success in the last decade, the sun doesn't always shine and the wind doesn't always blow.

Eight years ago, Congress passed the Affordable Care Act to address the HHS Office of Inspector General reports of drug manufacturers overcharging 340B drugs.

I'm happy to once again support my colleague Mr. Engel's bill, to rein in this dangerous practice.

The Sustainable Growth Rate (SGR) was a thorn in the side of Medicare and doctors who treated Medicare patients for over a decade.